Class: Expansion (424)
Patent Number: 6911435
Lack of leukocyte production, leukopenia, is a major morbidity and mortality factor in patients recieving high dose chemotherapy, as well as after bone marrow transplant. This patent is very useful since it teaches how to expand hematopoietic stem cell production of leukocytes through administration of adenosine, a compound that is already clinically used.
The patent has two independent...
Inventors: Cohn, Ilan (Herzlia, IL); Fishman, Pnina (Herzlia, IL)
Assignee: Can-Fite Biopharma Ltd. (Petach Tikva, IL)
Date of First Priority Issue: Thursday July 10th, 1997
Patent Number: 6136952
This patent covers the composition of matter of JAGGED and various peptide derivatives. JAGGED is important embryonically for development, as well it has stimulatory activity on a wide variety of stem cells.
Inventors: Li, Linheng (Seattle, WA); Hood, Leroy (Seattle, WA)
Assignee: University of Washington (Seattle, WA)
Date of First Priority Issue: Wednesday June 25th, 1997
Patent Number: 7,118,748
This patent covers the use of angiogensinogen I, II and specific derivatives for stimulation of hematopoietic and stem cell proliferation.
Inventors: Rodgers; Kathleen E. (Long Beach, CA), diZerega; Gere S. (Pasadena, CA)
Assignee: University of Southern California (Los Angeles, CA)
Date of First Priority Issue: Thursday May 8th, 1997
Patent Number: 5948426
This patent covers a matrix derived from bone that is able to induce the proliferation and expansion of hematopoietic stem cells in vitro.
Inventor: Jefferies, Steven R. (York, PA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Saturday May 3rd, 1997
Patent Number: 7094424
This patent teaches ways of selectively targeting a compound to endothelial cells. This could be used to administer stem cell stimulators in order to increase angiogenesis. The patent has one independent claim,that is "A method for selectively labeling angiogenic endothelial cells in vivo, the method comprising administering to a mammal a liposomal complex comprising cationic lipids and a...
Inventors: McDonald, Donald M. (San Francisco, CA); McLean, John (Redwood City, CA); Thurston, O. Gavin (San Francisco, CA); Baluk, Peter (San Francisco, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Date of First Priority Issue: Wednesday March 12th, 1997
Patent Number: 6713065
This patent covers the use of hedgehog proteins for stimulation of hematopoiesis and angiogenesis. The hedgehog proteins are critically involved in embryogenesis and developmental biology. Given the numerous similarities between stem cells and embryonic cells in general, the notion that hematopoietic stem cells still respond to embryonic signals is intriguing.
Inventors: Baron, Margaret H. (New York, NY); Farrington, Sarah M. (Cambridge, MA); Belaoussoff, Maria (Gottingen, DE)
Assignee: President and Fellows of Harvard College (Cambridge, MA)
Date of First Priority Issue: Monday February 10th, 1997
Patent Number: 6335195
This patent teaches that angiotensinogen I, II, and analogues thereof, are useful for the stimulation of mesenchymal and/or hematopoietic stem cell proliferation and/differentiation.
Inventors: Rodgers, Kathleen E. (Long Beach, CA); DiZerega, Gere S. (Pasadena, CA)
Assignee: Maret Corporation (Newport Beach, CA)
Date of First Priority Issue: Tuesday January 28th, 1997
Patent Number: 6642216
This patent covers inhibitors of the isoprenoid pathway which can be used for stimulation of osteoblast and other bone stem cells in order to stimulate growth of bone.
Inventors: Gasper, Shirley R. (Seattle, WA); West, Robert R. (Seattle, WA); Martinez, Theresa (Greenback, WA); Robbins, Kirk G. (Renton, WA); McKernan, Patricia A. (Woodinville, WA); Baindur, Nand (Edmonds, WA); Labroo, Virender M. (Bangalore, IN); Mundy, Gregory R.
Assignee: ZymoGenetics Corporation (Seattle, WA); OsteoScreen, Inc. (San Antonio, TX)
Date of First Priority Issue: Friday December 13th, 1996
Patent Number: 6077857
This patent provides compositions of matter that stimulate hematopoietic stem cell proliferation. These compounds appear to be small molecules and have an acceptable safety profile in the data provided.
Inventors: Bhatnagar, Pradip Kumar (Exton, PA); Heerding, Dirk Andries (Malvern, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Date of First Priority Issue: Tuesday November 12th, 1996
Patent Number: 6063593
This patent teaches that tranforming growth factor beta treatment of hematopoietic stem cells will make them more susceptible to gene transfection.
Inventors: Gordon, Erlinda Maria (Glendale, CA); Hall, Frederick L. (Glendale, CA); Anderson, W. French (San Marino, CA)
Assignee: University of Southern California University Park Campus (Los Angeles, CA)
Date of First Priority Issue: Tuesday November 12th, 1996